PDL Biopharma
PDLI
#8017
Rank
A$0.40 B
Marketcap
A$3.52
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Market capitalization of PDL Biopharma (PDLI)

Last known market cap: A$0.40 Billion

As of March 2026 PDL Biopharma has a market cap of A$0.40 Billion. This makes PDL Biopharma the world's 8017th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PDL Biopharma from 2001 to 2021

End of year Market Cap

Year Marketcap Change
2021A$0.38 B6.06%
2020A$0.36 B-36.31%
2019A$0.57 B2.52%
2018A$0.56 B3.74%
2017A$0.54 B11.26%
2016A$0.48 B-39.01%
2015A$0.79 B-47.75%
2014A$1.52 B15.4%
2013A$1.32 B39.79%
2012A$0.94 B12.02%
2011A$0.84 B-1.27%
2010A$0.85 B-6.17%
2009A$0.91 B-12.81%
2008A$1.04 B-55.57%
2007A$2.35 B-19.81%
2006A$2.93 B-32.49%
2005A$4.35 B70.08%
2004A$2.55 B13.19%
2003A$2.26 B68.04%
2002A$1.34 B-76.44%
2001A$5.71 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Eli Lilly
LLY
A$1.155 T 287,527.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$266.93 B 66,351.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.17 B-56.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A$0.28 B-29.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
A$2.94 B 634.33%๐Ÿ‡บ๐Ÿ‡ธ USA